UBS Group’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,697
| Closed | -$75 | – | 8987 |
|
2024
Q1 | $75 | Buy |
+4,697
| New | +$75 | ﹤0.01% | 7708 |
|
2023
Q4 | – | Sell |
-100
| Closed | -$4 | – | 8859 |
|
2023
Q3 | $4 | Buy |
+100
| New | +$4 | ﹤0.01% | 8164 |
|
2023
Q2 | – | Sell |
-687
| Closed | -$48 | – | 8699 |
|
2023
Q1 | $48 | Sell |
687
-7,536
| -92% | -$527 | ﹤0.01% | 8244 |
|
2022
Q4 | $329 | Buy |
+8,223
| New | +$329 | ﹤0.01% | 9043 |
|
2022
Q3 | – | Sell |
-289
| Closed | – | – | 9924 |
|
2022
Q2 | $0 | Sell |
289
-1
| -0.3% | – | ﹤0.01% | 9954 |
|
2022
Q1 | $0 | Buy |
290
+90
| +45% | – | ﹤0.01% | 9796 |
|
2021
Q4 | $0 | Sell |
200
-4,177
| -95% | – | ﹤0.01% | 9544 |
|
2021
Q3 | $1K | Sell |
4,377
-190
| -4% | -$43 | ﹤0.01% | 8129 |
|
2021
Q2 | $2K | Buy |
+4,567
| New | +$2K | ﹤0.01% | 7892 |
|